A Phase I Study of Onivyde and 5-FU in Combination With Xilonix for Advanced Pancreatic Cancer With Cachexia

Trial Profile

A Phase I Study of Onivyde and 5-FU in Combination With Xilonix for Advanced Pancreatic Cancer With Cachexia

Recruiting
Phase of Trial: Phase I

Latest Information Update: 09 Nov 2017

At a glance

  • Drugs Irinotecan (Primary) ; MABp1 (Primary) ; Fluorouracil; Folinic acid
  • Indications Cachexia; Pancreatic cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Oct 2017 According to an XBiotech media release, the first patient has been enrolled in this trial.
    • 18 Oct 2017 According to an XBiotech media release, status changed from not yet recruiting to recruiting.
    • 07 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top